Table 5. QOL evaluation (LC13).

	Before therapy n=34	After 4 weeks n=32	After 12 weeks n=20
Symptom scales/items
Dyspnoea	12.5±17.1	14.0±17.7	11.1±16.4
Coughing	32.3±15.8	24.7±21.0	22.2±16.4
Haemoptysis	4.2±11.2	8.6±17.1	8.3±15.1
Sore mouth	6.3±9.9	9.7±17.6	5.6±13.0
Dysphagia	3.1±9.9	6.5±15.9	11.1±16.4
Peripheral neuropathy	15.6±17.2	14.0±18.8	13.9±17.2
Alopecia	3.1±13.0	7.5±18.7	16.7±17.4*
Chest pain	10.4±15.7	7.5±14.2	13.9±17.2
Arm or shoulder pain	7.3±18.4	10.8±18.0	19.4±33.2
Pain in other regions	26.9±27.8	18.3±20.8	16.7±17.4

QOL=quality of life; LC13=lung-cancer-specific module.

^*P<0.05 compared with before therapy.